Won S J, Chuang Y C, Huang W T, Liu H S, Lin M T
Department of Microbiology, National Cheng Kung University, Medical College, Tainan City, Taiwan, Republic of China.
Experientia. 1995 Apr 15;51(4):343-8. doi: 10.1007/BF01928892.
The effects of dopaminergic receptor inhibitors such as thiothixine (D1/D2), fluphenazine (D1/D2), trifluoperazine (D1/D2), pimozide (D2), flupenthixol (D1/D2), (+/-)-SKF 83566 (D1), and spiperone (D2) on splenic natural killer (NK) cell cytotoxic activities were assessed in vitro using mouse spleen lymphocytes or enriched NK cells. Both the activities of the splenic NK cell cytotoxicity and the effector-target cell conjugation were suppressed by thiothixine, fluphenazine, and trifluoperazine at concentrations from 2.64 to 14.78 microM. In addition, the augmentation of the cytolytic activity of NK cells induced by interferon-alpha or interleukin-2 was antagonized by pretreatment with these neuroleptic compounds. However, neither the splenic NK cell cytotoxicity nor the effector-target cell conjugation were affected by treatment with other neuroleptic compounds such as pimozide, flupenthixol, (+/-)-SKF 83566, and spiperone. Thus, it appears that neuroleptic compounds such as thiothixine, fluphenazine, and trifluoperazine may act through the mechanisms other than a dopaminergic pathway to affect the NK cell-target cell interaction.
使用小鼠脾淋巴细胞或富集的自然杀伤(NK)细胞,在体外评估了硫利达嗪(D1/D2)、氟奋乃静(D1/D2)、三氟拉嗪(D1/D2)、匹莫齐特(D2)、氟哌噻吨(D1/D2)、(±)-SKF 83566(D1)和螺哌隆(D2)等多巴胺能受体抑制剂对脾NK细胞细胞毒性活性的影响。硫利达嗪、氟奋乃静和三氟拉嗪在浓度为2.64至14.78 microM时,均抑制了脾NK细胞的细胞毒性活性以及效应细胞与靶细胞的结合。此外,这些抗精神病化合物预处理可拮抗α-干扰素或白细胞介素-2诱导的NK细胞溶细胞活性增强。然而,匹莫齐特、氟哌噻吨、(±)-SKF 83566和螺哌隆等其他抗精神病化合物处理对脾NK细胞细胞毒性或效应细胞与靶细胞的结合均无影响。因此,硫利达嗪、氟奋乃静和三氟拉嗪等抗精神病化合物似乎可能通过多巴胺能途径以外的机制来影响NK细胞与靶细胞的相互作用。